ENTRY       K08862                      KO
NAME        PLK3, CNK
DEFINITION  polo-like kinase 3 [EC:2.7.11.21]
PATHWAY     ko04068  FoxO signaling pathway
            ko05152  Tuberculosis
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signal transduction
               04068 FoxO signaling pathway
                K08862  PLK3, CNK; polo-like kinase 3
             Human Diseases
              Infectious diseases
               05152 Tuberculosis
                K08862  PLK3, CNK; polo-like kinase 3
            Enzymes [BR:ko01000]
             2. Transferases
              2.7  Transferring phosphorus-containing groups
               2.7.11  Protein-serine/threonine kinases
                2.7.11.21  polo kinase
                 K08862  PLK3, CNK; polo-like kinase 3
            Protein kinases [BR:ko01001]
             Serine/threonine protein kinases: Other group
              PLK family [OT]
               K08862  PLK3, CNK; polo-like kinase 3
            Chromosome [BR:ko03036]
             Eukaryotic Type
              Sister chromatid separation proteins
               Polo kinases
                K08862  PLK3, CNK; polo-like kinase 3
GENES       HSA: 1263(PLK3)
            PTR: 456546(PLK3)
            PPS: 100973032(PLK3)
            GGO: 101143772(PLK3)
            PON: 100433480(PLK3)
            MCC: 704071(PLK3)
            MCF: 102130926(PLK3)
            MMU: 12795(Plk3)
            RNO: 58936(Plk3)
            CGE: 100762491(Plk3)
            HGL: 101702778(Plk3)
            TUP: 102500186(PLK3)
            CFA: 475380(PLK3)
            AML: 100475589(PLK3)
            FCA: 101088599(PLK3)
            PTG: 102960020(PLK3)
            BTA: 504282(PLK3)
            BOM: 102273124(PLK3)
            PHD: 102323123(PLK3)
            SSC: 397250(PLK3)
            CFR: 102506528(PLK3)
            BACU: 103018493(PLK3)
            LVE: 103070984(PLK3)
            ECB: 100065793(PLK3)
            MYB: 102239886(PLK3)
            MYD: 102752290(PLK3)
            PALE: 102886992(PLK3)
            MDO: 100024987(PLK3)
            SHR: 100917173(PLK3)
            OAA: 100091573(PLK3)
            GGA: 424586(PLK3)
            MGP: 100545840(PLK3)
            TGU: 100221236(PLK3)
            FAB: 101813168(PLK3)
            PHI: 102108445(PLK3)
            APLA: 101797863(PLK3)
            FPG: 101914988(PLK3)
            FCH: 102049980(PLK3)
            CLV: 102090340(PLK3)
            ASN: 102375098(PLK3)
            AMJ: 102560421(PLK3)
            PSS: 102452285(PLK3)
            CMY: 102930864(PLK3)
            ACS: 100559459(plk3)
            PBI: 103065204(PLK3)
            XTR: 448451(plk3)
            DRE: 334202(plk3)
            TRU: 101066743
            MZE: 101475303
            OLA: 101155385
            XMA: 102216895
            LCM: 102355147(PLK3)
            CIN: 100183083
REFERENCE   PMID:21750699
  AUTHORS   McMillin DW, Delmore J, Negri J, Ooi M, Klippel S, Miduturu CV, Gray NS, Richardson PG, Anderson KC, Kung AL, Mitsiades CS
  TITLE     Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translation.
  JOURNAL   PLoS One 6:e20226 (2011)
///
